Angion Biomedica Corp Stock Ownership - Who owns Angion Biomedica?

Insider buying vs selling

Have Angion Biomedica Corp insiders been buying or selling?
Itzhak GoldbergDirector2022-07-0132,082$1.12
Jay VenkatesanDirector2022-05-2511,313$1.25
Jay VenkatesanPresident and Chief Executive Officer and Director2022-05-2432,200$1.24
Allen NissensonDirector2022-05-202,037$1.18
Jay VenkatesanPresident and Chief Executive Officer and Director2022-05-2050,000$1.23
Allen NissensonDirector2022-05-197,346$1.16

1 of 1

ANGN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANGN insiders and whales buy or sell their stock.

ANGN Shareholders

What type of owners hold Angion Biomedica Corp stock?
Eisaabc LLC9.10%2,740,978$1.59MInsider
Jay Venkatesan6.28%1,891,947$1.10MInsider
Itzhak Goldberg5.61%1,687,986$979.03kInsider
Bvf Inc3.56%1,071,297$621.35kInstitution
Nantahala Capital Management LLC3.43%1,033,145$599.22kInstitution
Victor F. Ganzi3.25%978,698$567.64kInsider
Cm Management LLC2.43%732,178$424.66kInstitution
Vanguard Group Inc2.14%644,035$373.54kInstitution
Park West Asset Management LLC1.23%370,724$215.02kInstitution
Bridgeway Capital Management LLC0.58%175,000$101.50kInstitution

1 of 3

ANGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANGN16.31%24.83%Net Buying
TFFP28.28%17.96%Net BuyingNet Buying
ERNA0.38%99.62%Net Buying
GOVX0.82%99.18%Net Buying
AIMD0.29%67.56%Net Buying

Angion Biomedica Stock Ownership FAQ

Who owns Angion Biomedica?

Angion Biomedica (NASDAQ: ANGN) is owned by 16.31% institutional shareholders, 24.83% Angion Biomedica insiders, and 58.86% retail investors. Eisaabc LLC is the largest individual Angion Biomedica shareholder, owning 2.74M shares representing 9.10% of the company. Eisaabc LLC's Angion Biomedica shares are currently valued at $1.59M.

If you're new to stock investing, here's how to buy Angion Biomedica stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.